Certified by Founder Lodge
Longevity Vision Fund
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $300,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer, healthier lives. The
| Company | Date | Round | Raised |
|---|---|---|---|
 Tessera Therapeutics |
April, 19 ,2022 | Series C | $300,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
